The Singapore Labs was established, following the success of the group’s labs in Israel.
“After four years of rapid growth – including the creation and development of 11 Singapore-based companies, we are delighted to go one step further and formally establish a Singapore-based team to provide in-house product conceptualization and development of novel medical devices,” said Eric Loh, CEO of Trendlines Medical Singapore.
Agreeing, the group’s chairman and CEO, Todd Dollinger believes Labs Singapore will “create value through the invention and development of market-oriented medical technologies for our portfolio companies and strategic partners.”
Shares of Trendlines closed up 0.5 cents or 4.72% at 11.1 cents on August 5.
